Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment.

Anthony, R M

Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment. [electronic resource] - Antimicrobial agents and chemotherapy 06 2017

Publication Type: Letter; Comment

1098-6596

10.1128/AAC.00258-17 doi


Amidohydrolases--genetics
Antitubercular Agents
Humans
Microbial Sensitivity Tests
Mutation
Mycobacterium tuberculosis
Pyrazinamide
Tuberculosis, Multidrug-Resistant